RxNorm 2709119 NDC Crossover
influenza virus vaccine 2025 (quadrivalent - Croatia/Victoria/Michigan/Phuket) 0.5 ML
Related NDC Codes to RxNorm Concept 2709119
The following NDC codes crossover to the RxNorm Concept 2709119. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 49281-324 | Fluzone Quadrivalent Southern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-326 | Fluzone Qiv Sh 2025 | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-357 | Fluzone Qiv Sh 2025 | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-398 | Fluzone Quadrivalent Southern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-418 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-420 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-421 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-422 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-423 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-519 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-539 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-541 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
| 49281-629 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-631 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-633 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-635 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-637 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-639 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-924 | Fluzone Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | |||||
| 49281-926 | Fluzone Quadrivalent Northern Hemisphere | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Sanofi Pasteur Inc. | ACTIVE |
